Global Rheumatoid Arthritis Market Report: 2016 Edition - New Report by Koncept Analytics

1
Global Rheumatoid Arthritis Market
----------------------------------------- 2016
View Report Details
2
View Report Details

• Executive Summary
• Arthritis means inflammation in a joint.
  Inflammation is a normal immune response in a
  body. It happens when the body, no longer has the
  ability to turn off the inflammatory response and
  thereby start damaging the healthy tissues of the
  body.
• Inflammation causes redness, warmth, swelling,
  and pain within the joint. There are more than
  100 different types of arthritis, with different
  causes and treatment methods. Major
  classification of arthritis includes degenerative
  arthritis, inflammation arthritis, infectious and
  metabolic arthritis.
• Rheumatoid arthritis or RA is classified under
  inflammatory arthritis. It is a chronic
  autoimmune disease.
• About 1 out of every 5 people who suffer from
  rheumatoid arthritis get lumps on their skin
  called rheumatoid nodules. This disease occurs in
  4 main stages and can be diagnosed with certain
  blood tests, medical history, and imaging tests.
  There is no cure for rheumatoid arthritis, but
  there are various treatments available that
  reduce the pain like drugs, physical exercise or
  surgery.
• The rheumatoid arthritis market is expected to
  grow in the coming years with growing demand for
  better medical facilities and more effective
  drugs.
• The US rheumatoid arthritis market dominates the
  global market with larger number of rheumatoid
  arthritis patients.
• The key trends of the market include increasing
  competition from anti-IL6 drugs, rising FDA
  approvals to RA drugs, use of complementary and
  alternative medicines, and increasing share of
  biosimilars.
• The key factors driving the growth of the RA
  market includes increasing women population,
  escalating global ageing population, rising
  health care expenditure, rising cigarette
  consumption, and increasing obese population.
• However, there are certain factors which hinder
  the growth of the rheumatoid arthritis market
  like high cost of treatment and high research and
  development cost.
• The report offers an in-depth analysis of the
  Global Rheumatoid Arthritis Market segmented
  into global and regional market.
• Competition is concentrated in the hands of few
  major pharmaceutical companies. Major RA
  companies that have been covered in the report
  include AbbVie, JNJ, Amgen Inc. and Pfizer Inc.

3
Global Rheumatoid Arthritis market is expected to
grow significantly in the coming years driven by
several factors including increasing female
population, escalating global health care
expenditure, rising FDA approvals, rising
cigarette consumption
Global Rheumatoid Arthritis Market by Value
(2015-2020E)

• The revenue of the global rheumatoid arthritis
  market is expected to be recorded at US..
  billion by 2020, increasing from US.. billion in
  the year 2015. It is expected to record growth at
  a CAGR of .. for the period spanning from
  2015-2020.
• The market for XX is expected to account for
  revenue worth US.. billion by 2020, increasing
  from US.. billion in year 2015.
• XX is expected to record revenue worth US..
  billion by 2020, an increase from US.. billion
  in 2015.
• XX is expected to hold the maximum revenue share
  of .. in 2016, followed by XX with .. revenue
  share in the year 2016.

Global Rheumatoid Arthritis Market by Drug Class
(2015/2020E)
Global Rheumatoid Arthritis Market Share by Drug
(2016E)
4
The regional rheumatoid arthritis markets were
driven by increasing ageing population,
prevalence of smoking, increased inactivity...
The US Rheumatoid Arthritis Market by Value
(2015-2020E)

• The revenue of rheumatoid arthritis market in the
  US is expected to be recorded at US.. billion by
  2020, increasing from US.. billion in the year
  2015, growing at a CAGR of .. for the period
  spanning from 2015-2020.
• The total number of patients with rheumatoid
  arthritis in the US is expected to reach ..
  million by 2020, increasing from .. million in
  the year 2015.
• The total rheumatoid arthritis population in the
  US on XX is expected to reach .. thousand by
  2020, increasing from .. thousand populations in
  2015.
• The population on anti-TNFs in the US is expected
  to record a growth at a CAGR of .. for the
  period spanning 2015-2020.

The US Rheumatoid Arthritis Patient Prevalence
(2015-2020E) )
The US Rheumatoid Arthritis Anti-TNF Population
(2015-2020E)
5
The global rheumatoid arthritis market is
concentrated with major pharmaceutical companies
dominating the market through new drug approval
Global Rheumatoid Arthritis Market Share by
Company (2015/2020E)

• AbbVie had .. of the market share for the year
  2015 and is expected to record a rise of . by
  2020.
• JNJ and PEF are expected to register an increase
  of . in their market share by 2020.
• Enbrel produce by Amgen is expected to record ..
  of the total market share in 2016.
• AbbVies Humira is expected to account .. of the
  revenue share in 2016 .
• By 2020, the US population on biologic drug
  treatment is expected to reach .. thousand,
  increasing from .. thousand in the year 2015.

The US Rheumatoid Arthritis Brand (Company) Share
(2016E)
The US Rheumatoid Arthritis Biologics Population
(2015-2020E)
6
Contact Us
View Report Details
These are abridged and sanitized sample pages
from the comprehensive report on the Global
Rheumatoid Arthritis Market- 2016 Edition . To
know more about this report or for any customized
research requirement, please contact the
following
Koncept Analytics CS-36, Second Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T.
91-120-4130959 C 91-9811715635
vikas_at_konceptanalytics.com
Vikas Gupta BD Manager
www.konceptanalytics.com